Search - tctmd.com

Displaying 221 - 240 of 475

Sort: Relevancy | Date

Presentation TCT 2017

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

Presenter: Mitchell W. Krucoff, John C Laschinger, Daniel A Canos

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Gregory J. Dehmer

October 30, 2017

Presentation TCT 2017

National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions

Presenter: Mitchell W. Krucoff, John C Laschinger, Rachael L. Fleurence

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

Presentation TCT 2017

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

Presenter: Mitchell W. Krucoff, John C Laschinger, E. Murat Tuzcu

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Holger Thiele

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

Enhancing Pre-Approval Studies to Better Evaluate Real-World Use: Lessons Learned and Future Opportunities

Presenter: Mitchell W. Krucoff, John C Laschinger

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI With Multivessel Disease How We Treated

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Jacqueline E. Tamis-Holland

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Stefan K. James

October 30, 2017

Presentation TCT 2017

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Presenter: Jeroen J. Bax, Axel Linke, Alec S. Vahanian

October 29, 2017

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

Presentation ESC 2017

Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation

Presenter: Borja Ibanez

August 28, 2017

Presentation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

August 22, 2017

Presentation

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

August 14, 2017

Presentation

Trends and Outcomes of Off-Label Use of TAVR in 23,847 Patients in TVT Registry

June 22, 2017

Presentation TVT 2017

The 2017 AHA/ACC Focused Update of the Guidelines for Managing Aortic Valve Disease: Take-home Messages for the Clinician

Presenter: Robert O. Bonow, Martin B. Leon, Allan Schwartz

June 15, 2017

Advertisement

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions

New U.S. Hypertension Guidelines and Treatment Targets

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Enhancing Pre-Approval Studies to Better Evaluate Real-World Use: Lessons Learned and Future Opportunities

Case Resolution: STEMI With Multivessel Disease How We Treated

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Guidelines for the Management of Valvular Heart Disease

Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

Trends and Outcomes of Off-Label Use of TAVR in 23,847 Patients in TVT Registry

The 2017 AHA/ACC Focused Update of the Guidelines for Managing Aortic Valve Disease: Take-home Messages for the Clinician

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content